{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:43:15Z","timestamp":1791931395774,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR12-22"],"award-info":[{"award-number":["W.OR12-22"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR18-07"],"award-info":[{"award-number":["W.OR18-07"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinph.2024.02.036","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:54:26Z","timestamp":1709816066000},"page":"2010404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The complementary use of muscle ultrasound and MRI in FSHD: Early versus later disease stage follow-up"],"prefix":"10.1016","volume":"181","author":[{"given":"Sanne C.C.","family":"Vincenten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9841-6909","authenticated-orcid":false,"given":"Donnie","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G.M.","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nens","family":"van Alfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Mul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2024.02.036_b0005","unstructured":"Adminstration USFD. About Biomarkers and Qualification; 2021. Available from: https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/about-biomarkers-and-qualification#:\u223c:text=A%20biomarker%20is%20not%20an,feels%2C%20functions%2C%20or%20survives.&text=BEST%20defines%20seven%20biomarker%20categories,pharmacodynamic%2Fresponse%2C%20and%20safety. 2023]."},{"issue":"7","key":"10.1016\/j.clinph.2024.02.036_b0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"A motor function measure scale for neuromuscular diseases. Construction and validation study","volume":"15","author":"B\u00e9rard","year":"2005","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1016\/j.clinph.2024.02.036_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mus.27211","article-title":"Diagnostic accuracy of gray scale muscle ultrasound screening for pediatric neuromuscular disease","volume":"64","author":"Boon","year":"2021","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1016\/j.clinph.2024.02.036_b0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-017-00730-1","article-title":"Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model","volume":"8","author":"Bosnakovski","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23041983","article-title":"Persistent fibroadipogenic progenitor expansion following transient DUX4 expression provokes a profibrotic state in a mouse model for FSHD","volume":"23","author":"Bosnakovski","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clinph.2024.02.036_b0030","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1172\/JCI133303","article-title":"Transcriptional and cytopathological hallmarks of FSHD in chronic DUX4-expressing mice","volume":"130","author":"Bosnakovski","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.clinph.2024.02.036_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-160145","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials","volume":"3","author":"Carlier","year":"2016","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"9","key":"10.1016\/j.clinph.2024.02.036_b0040","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1212\/WNL.0000000000010155","article-title":"Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy","volume":"95","author":"Dahlqvist","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.25804","article-title":"MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy","volume":"88","author":"Dahlqvist","year":"2020","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.clinph.2024.02.036_b0050","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.clinph.2024.02.036_b0055","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-022-05233-6","article-title":"Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients","volume":"13","author":"Di Pietro","year":"2022","journal-title":"Cell Death Dis"},{"issue":"21","key":"10.1016\/j.clinph.2024.02.036_b0060","doi-asserted-by":"crossref","first-page":"e2103","DOI":"10.1212\/WNL.0000000000012882","article-title":"Natural history of facioscapulohumeral dystrophy in children: A 2-Year Follow-up","volume":"97","author":"Dijkstra","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clinph.2024.02.036_b0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mus.26038","article-title":"MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1","volume":"57","author":"Ferguson","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2024.02.036_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-023-06842-5","article-title":"Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients","author":"Fionda","year":"2023","journal-title":"Neurol Sci"},{"issue":"6\u20137","key":"10.1016\/j.clinph.2024.02.036_b0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0960-8966(01)00201-2","article-title":"Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy","volume":"11","author":"Flanigan","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clinph.2024.02.036_b0080","unstructured":"Fulcrum-Therapeutics. Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH); 2022. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05397470."},{"issue":"3","key":"10.1016\/j.clinph.2024.02.036_b0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/ene.15174","article-title":"Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials","volume":"29","author":"Garibaldi","year":"2022","journal-title":"Eur J Neurol"},{"issue":"14","key":"10.1016\/j.clinph.2024.02.036_b0090","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1212\/WNL.0000000000009211","article-title":"Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy","volume":"94","author":"Goselink","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0095","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","article-title":"Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments","volume":"15","author":"Hamel","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.clinph.2024.02.036_b0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-3476(82)80286-2","article-title":"Ultrasound imaging in the diagnosis of muscle disease","volume":"101","author":"Heckmatt","year":"1982","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clinph.2024.02.036_b0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s43856-022-00217-1","article-title":"Whole-muscle fat analysis identifies distal muscle end as disease initiation site in facioscapulohumeral muscular dystrophy","volume":"2","author":"Heskamp","year":"2022","journal-title":"Commun Med (Lond)"},{"issue":"6","key":"10.1016\/j.clinph.2024.02.036_b0110","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/mus.24247","article-title":"Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy","volume":"50","author":"Janssen","year":"2014","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clinph.2024.02.036_b0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mus.21671","article-title":"A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score","volume":"42","author":"Lamperti","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0120","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JND-200543","article-title":"Correlation between quantitative MRI and muscle histopathology in muscle biopsies from healthy controls and patients with IBM, FSHD and OPMD","volume":"7","author":"Lassche","year":"2020","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"10.1016\/j.clinph.2024.02.036_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mus.26064","article-title":"Magnetic resonance imaging in facioscapulohumeral muscular dystrophy","volume":"57","author":"Leung","year":"2018","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.24569","article-title":"Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy","volume":"52","author":"Leung","year":"2015","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clinph.2024.02.036_b0135","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221115","article-title":"Assessment of extracellular volume fraction in becker muscular dystrophy by using MR fingerprinting","volume":"307","author":"Marty","year":"2023","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clinph.2024.02.036_b0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","article-title":"Muscle MRI in inherited neuromuscular disorders: Past, present, and future","volume":"25","author":"Mercuri","year":"2007","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"1","key":"10.1016\/j.clinph.2024.02.036_b0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nmd.2022.10.005","article-title":"265th ENMC international workshop: Muscle imaging in facioscapulohumeral muscular dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands","volume":"33","author":"Monforte","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.clinph.2024.02.036_b0150","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/CON.0000000000001155","article-title":"Facioscapulohumeral muscular dystrophy","volume":"28","author":"Mul","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"11","key":"10.1016\/j.clinph.2024.02.036_b0155","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s00415-018-9037-y","article-title":"Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers","volume":"265","author":"Mul","year":"2018","journal-title":"J Neurol"},{"issue":"20","key":"10.1016\/j.clinph.2024.02.036_b0160","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1212\/WNL.0000000000004647","article-title":"Adding quantitative muscle MRI to the FSHD clinical trial toolbox","volume":"89","author":"Mul","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2024.02.036_b0165","unstructured":"Neuromuscular. Facioscapulohumeral (FSH) Dystrophy; Pathology; 2022. Available from: https:\/\/neuromuscular.wustl.edu\/pathol\/fsh.htm."},{"issue":"3","key":"10.1016\/j.clinph.2024.02.036_b0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ultrasmedbio.2008.09.016","article-title":"Skeletal muscle ultrasound: correlation between fibrous tissue and echo intensity","volume":"35","author":"Pillen","year":"2009","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.clinph.2024.02.036_b0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7863\/jum.1993.12.2.73","article-title":"Skeletal muscle sonography: a correlative study of echogenicity and morphology","volume":"12","author":"Reimers","year":"1993","journal-title":"J Ultrasound Med"},{"issue":"6","key":"10.1016\/j.clinph.2024.02.036_b0180","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M","article-title":"Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype","volume":"45","author":"Ricci","year":"1999","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.clinph.2024.02.036_b0185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nature Methods"},{"issue":"5","key":"10.1016\/j.clinph.2024.02.036_b0190","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1172\/JCI136133","article-title":"It\u2019s not all about muscle: fibroadipogenic progenitors contribute to facioscapulohumeral muscular dystrophy","volume":"130","author":"Serra","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.clinph.2024.02.036_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2016.01.041","article-title":"Skeletal muscle imaging in neuromuscular disease","volume":"33","author":"Simon","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0200","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mus.24621","article-title":"Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies","volume":"52","author":"Statland","year":"2015","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0205","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mus.27174","article-title":"Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1","volume":"63","author":"van der Plas","year":"2021","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0210","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/jcsm.13250","article-title":"Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome","volume":"14","author":"Vincenten","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clinph.2024.02.036_b0215","doi-asserted-by":"crossref","unstructured":"Vincenten SCCTS, Voermans NC, van Engelen BGM, Mul K, van Alfen N. Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy Neuromuscul Disord 2023.","DOI":"10.1016\/j.nmd.2023.10.015"},{"issue":"1","key":"10.1016\/j.clinph.2024.02.036_b0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12891-021-04134-7","article-title":"Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"10.1016\/j.clinph.2024.02.036_b0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.27081","article-title":"Muscle ultrasound: Present state and future opportunities","volume":"63","author":"Wijntjes","year":"2021","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clinph.2024.02.036_b0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.27669","article-title":"Visual versus quantitative analysis of muscle ultrasound in neuromuscular disease","volume":"66","author":"Wijntjes","year":"2022","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.clinph.2024.02.036_b0235","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1212\/WNL.0000000000005915","article-title":"A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1","volume":"91","author":"Wohlgemuth","year":"2018","journal-title":"Neurology"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245724000646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245724000646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T22:52:20Z","timestamp":1768949540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245724000646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S1388245724000646"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2024.02.036","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complementary use of muscle ultrasound and MRI in FSHD: Early versus later disease stage follow-up","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2024.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"2010404"}}